https://nf-health-economics.com/2026/06/30/review-of-innovative-payment-models-for-sickle-cell-disease-gene-therapies-in-medicaid-leveraging-real-world-data-and-insights-from-cmmis-gene-therapy-access-model/Nermina Ferizovic | Health Economics Experten-gb2026-06-30T17:38:58+00:00Review of: “Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI’s Gene Therapy Access Model”